Mittwoch, 18. Dezember 2019

Startup Battlefield Competition: Session 3 - Genesis Therapeutics


Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news. Subscribe to TechCrunch today: http://bit.ly/18J0X2e https://ift.tt/38OgMuH TechCrunchhttp://ifttt.com/images/no_image_card.pngDecember 17, 2019 at 06:40PM https://ift.tt/eA8V8J

Keine Kommentare: